![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Twist Bioscience Incorporates MOLCURE AI Technology to Augment Therapeutic Antibody Discovery
Twist Bioscience Corporation , a company enabling customers to succeed through its offering of high-quality...
Abzena and BioXpress Therapeutics announce partnership to support the development and manufacture of biosimilars...
Abzena, a Global Partner Research Organization for integrated bench to patient solutions for biologics and...
Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC Protein Degrader ARV-471
Arvinas, Inc. and Pfizer Inc. announced a global collaboration to develop and commercialize ARV-471, an...
Kineta and Samsung Biologics Announce Development and Manufacturing Agreement for Anti-VISTA Antibody Immunotherapy
Samsung Biologics, one of the world’s leading contract development and manufacturing organization (CDMO), signed a...
LGM Pharma launches standalone analytical services for drug developers and manufacturers
LGM Pharma announced the launch of its new Analytical Services offering that provides analytical testing...
Novasep signs a manufacturing services agreement with Exelixis for a next-generation ADC
Novasep, a leading supplier of services and technologies for the life sciences industry, is pleased...
I-Mab Announces Multiple Advancements of 4-1BB Bispecific Antibody Portfolio
I-Mab, a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, ...
Batavia to develop innovative clinical process for RocketVax’s second generation COVID-19 vaccine
Batavia Biosciences announces their collaboration with RocketVax, a subsidiary of Swiss Rockets AG developing vaccines...
I-Mab Expands Emerging Portfolio of Next Generation Novel Oncology Therapeutics Through Cutting-Edge mRNA and...
I-Mab, a clinical stage biopharmaceutical company committed to the discovery, development and commercialization of novel...
Vaxart Announces Exclusive Worldwide License Agreement with Altesa Biosciences for its Vapendavir Antiviral Asset
Vaxart, Inc., a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet...